TrialArthritis research & therapy2016

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.

George P Karamanolis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.